KREBSBIOMARKER

Patent europeic · EP3524697 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3524697
Numer da la dumonda
EP18209293
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-01-2010
Publitgà
14-08-2019
Concedì
02-10-2024
La protecziun finescha il pli tard
06-01-2030
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
C12Q 1/6886 (2018.01)
G01N 33/574 (2006.01)
Prioritad
US 14307709 P 07.01.2009
US 17965009 P 19.05.2009
US 18590109 P 10.06.2009
US 24174809 P 11.09.2009
US 25644309 P 30.10.2009
Derivà da
EP16170659
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 13-08-2025

    Midada

    Published in Swissreg on 13.08.2025

  3. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  4. 13-11-2024

    Represchentant inscrit

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 13.11.2024

  5. 03-10-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Partidas

Possessur

Myriad Genetics, Inc.

320 Wakara Way, Salt Lake City, UT 84108, US

Represchentant

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventur

Stone, Steve

Salt Lake City, UT 84108, US

Gutin, Alexander

Salt Lake City, UT 84108, US

Wagner, Susanne

Salt Lake City, UT 84108, US

Reid, Jutta

Salt Lake City, UT 84108, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.